Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR–Cas9 and ssODN in human cancer cellsZheng Hu(Central South University), Yuan‐Shan Zhu(Cornell University)Cell & BioscienceFebruary 19, 201810.1186/s13578-018-0200-zCited by 84SaveCiteExport RISWatch citationsRelated PapersTargeted disruption of the <italic>BCR-ABL</italic> fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells|Acta Biochimica et Biophysica Sinica|2023|1